Raw Materials in the Manufacture of Biotechnology Products: Regulatory Considerations

References

1. 1.↵
   ICH Q9, Quality risk management. International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use. June 2, 2006.
2. 2.↵
   U.S. Code of Federal Regulations, Title 21, Part 610.15. Constituent Materials. Food and Drugs, General Biological Products Standards. Office of the Federal Register, National Archives and Records Administration, U.S. Government Printing Office, Washington, DC. April 1, 2009.
3. 3.↵
   U.S. Code of Federal Regulations, Title 21, Part 211.80. Subpart E, Control of components and drug product containers and closures—General requirements. Office of the Federal Register, National Archives and Records Administration, U.S. Government Printing Office, Washington, DC. January 1, 2010.
4. 4.↵
   U.S. Code of Federal Regulations, Title 21, Part 211.110. Sampling and testing of in-process materials and drug products. Office of the Federal Register, National Archives and Records Administration, U.S. Government Printing Office, Washington, DC. April17, 2008.
5. 5.↵
   ICH Q7. Good manufacturing practice guide for active pharmaceutical ingredients. International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use. September 25, 2001.
6. 6.↵
   ICH Q6b. Specifications: Test procedures and acceptance criteria for biotechnological/biological products. International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use. March 10, 1999.
7. 7.↵
   1. Beck G.,
   2. Schenerman M.,
   3. Dougherty J.,
   4. Cordoba-Rodriguez R.,
   5. Joneckis C.,
   6. Mire-Sluis A.,
   7. McLeod L. D.

   Raw material control strategies for bioprocesses. Bioprocess International 2009, 7 (8), 18–33.

   OpenUrl
8. 8.↵
   ICH Q5A (R1). Viral safety evaluation of biotechnology products derived from cell lines of human or animal origin. International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use. September 23, 1999.
9. 9.↵
   ICH Q5D. Guidance on derivation and characterization of cell substrates used for production of biotechnological/biological products. International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use. September 21, 1998.
10. 10.↵
    1. Nims R. W.

    Detection of adventitious viruses in biologicals—a rare occurrence. Dev. Biol. (Basel) 2006, 123, 153–164.

    OpenUrlPubMed
11. 11.↵
    1. Rabenau H.,
    2. Ohlinger V.,
    3. Anderson J.,
    4. Selb B.,
    5. Cinatl J.,
    6. Wolf W.,
    7. Frost J.,
    8. Mellor P.,
    9. Doerr H. W.

    Contamination of genetically engineered CHO-cells by epizootic haemorrhagic disease virus (EHDV). Biologicals 1993, 21 (3), 207–214.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Garnick R.

    Raw materials as a source of contamination in large-scale cell culture. Dev. Biol. Stand. 1998, 93, 21–29.

    OpenUrlPubMedWeb of Science
13. 13.↵
    1. Bethencourt V.

    Virus stalls Genzyme plant. Nature Biotechnology 2009, 27 (8), 681.

    OpenUrlPubMed
14. 14.↵
    1. Masters J. R.

    HeLa cells 50 years on: the good, the bad and the ugly. Nat. Rev. Cancer 2002, 2 (4), 315–319.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    Points to consider in the characterization of cell lines used to produce biologics, 1993; Center for Biologics Evaluation and Research, FDA.
16. 16.↵
    Note for guidance on minimizing the risk of transmitting animal spongiform encephalopathy agents via human and veterinary medicinal products. 2003; Committee for proprietary medicinal products (CPMP) and Committee for veterinary medicinal products (CVMP).
17. 17.↵
    1. Guerrini M.,
    2. Zhang Z.,
    3. Shriver Z.,
    4. Naggi A.,
    5. Masuko S.,
    6. Langer R.,
    7. Casu B.,
    8. Linhardt R. J.,
    9. Torri G.,
    10. Sasisekharan R.

    Orthogonal analytical approaches to detect potential contaminants in heparin. Proc. Natl. Acad. Sci. USA 2009, 106 (40), 16956–16961.

    OpenUrlAbstract/FREE Full Text